Suncoast Equity Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Suncoast Equity Management’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$97K	Sell	90,645 -12,644	-12%	-$15.9K	0.01%	90
2025 Q4	$156K	Hold	103,289	–	–	0.02%	85
2025 Q3	$140K	Hold	103,289	–	–	0.01%	87
2025 Q2	$125K	Hold	103,289	–	–	0.01%	82
2025 Q1	$101K	Buy	103,289 +80,645	+356%	+$91.9K	0.01%	79
2024 Q4	$25.8K	Sell	22,644 -67,356	-75%	-$88K	﹤0.01%	76
2024 Q3	$117K	Buy	90,000 +50,000	+125%	+$79.7K	0.01%	70
2024 Q2	$25.5K	Hold	40,000	–	–	﹤0.01%	71
2024 Q1	$44K	Buy	+40,000	New	+$43.4K	0.01%	71

Other funds holding MIRA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Suncoast Equity Management's MIRA Position: Q1 2026 in Review

Suncoast Equity Management reduced its MIRA Pharmaceuticals (MIRA) stake by 12% in Q1 2026, selling an estimated $15.9K and leaving 90,645 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #90.

Suncoast Equity Management first reported a position in MIRA in Q1 2024 and has held it in 9 quarters since. The position peaked at $156K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

Suncoast Equity Management held 90,645 shares of MIRA Pharmaceuticals worth $97K as of Q1 2026.
Suncoast Equity Management sold 12,644 MIRA Pharmaceuticals shares in Q1 2026, an estimated $15.9K.
MIRA Pharmaceuticals made up 0.01% of Suncoast Equity Management's portfolio in Q1 2026, its #90 holding.
Suncoast Equity Management first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Suncoast Equity Management's MIRA Pharmaceuticals position peaked at $156K in Q4 2025.
26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Suncoast Equity Management's 13F filing for Q1 2026, filed 8 May 2026.